NCT06099418 2024-09-20
Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
Nykode Therapeutics ASA
Phase 2 Withdrawn
Nykode Therapeutics ASA
OHSU Knight Cancer Institute
University Health Network, Toronto